Page last updated: 2024-08-26

arsenic and Coagulation, Disseminated Intravascular

arsenic has been researched along with Coagulation, Disseminated Intravascular in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's8 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cull, EH; Kwaan, HC1
Komatsu, N1
Fujita, H1
Gerber, JM; Grunwald, MR; Lipford, EH; McDonnell, MH; Smith, ET1
Lo-Coco, F; Testa, U1
Bian, S; Hao, L; Li, J; Wang, H; Wang, X; Wu, Q1
Manji, GA; Tallman, MS1
Choudhry, A; DeLoughery, TG1

Reviews

4 review(s) available for arsenic and Coagulation, Disseminated Intravascular

ArticleYear
The coagulopathy in acute promyelocytic leukaemia--what have we learned in the past twenty years.
    Best practice & research. Clinical haematology, 2014, Volume: 27, Issue:1

    Topics: Annexin A2; Anticoagulants; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Blood Coagulation Disorders; Blood Coagulation Tests; Carboxypeptidase B2; Disseminated Intravascular Coagulation; Fibrinolysis; Forecasting; Granulocyte Precursor Cells; Hemorrhagic Disorders; Humans; Leukemia, Promyelocytic, Acute; Oxides; Recombinant Proteins; Risk Factors; S100 Proteins; Thrombomodulin; Thrombophilia; Thromboplastin; Tretinoin; Urokinase-Type Plasminogen Activator

2014
[Treatment for acute promyelocytic leukemia].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2014, Volume: 55, Issue:10

    Topics: Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Benzoates; Clinical Trials, Phase III as Topic; Consolidation Chemotherapy; Disseminated Intravascular Coagulation; Gene Fusion; Humans; Induction Chemotherapy; Leukemia, Promyelocytic, Acute; Maintenance Chemotherapy; Molecular Targeted Therapy; Nuclear Proteins; Oxides; Promyelocytic Leukemia Protein; Receptors, Retinoic Acid; Recurrence; Remission Induction; Retinoic Acid Receptor alpha; Tetrahydronaphthalenes; Transcription Factors; Tretinoin; Tumor Suppressor Proteins

2014
Prognostic factors in acute promyelocytic leukemia: strategies to define high-risk patients.
    Annals of hematology, 2016, Volume: 95, Issue:5

    Topics: Antigens, CD; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Biomarkers, Tumor; Chromosome Aberrations; Disseminated Intravascular Coagulation; DNA-Binding Proteins; fms-Like Tyrosine Kinase 3; Hemorrhagic Disorders; Humans; Immunophenotyping; Leukemia, Promyelocytic, Acute; Leukocyte Count; Nuclear Proteins; Oncogene Proteins, Fusion; Oxides; Prognosis; Risk Factors; Tandem Repeat Sequences; Treatment Outcome; Tretinoin; Tumor Protein p73; Tumor Suppressor Proteins

2016
Bleeding and thrombosis in acute promyelocytic leukemia.
    American journal of hematology, 2012, Volume: 87, Issue:6

    Topics: Antifibrinolytic Agents; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Blood Coagulation Tests; Clinical Trials as Topic; Combined Modality Therapy; Cysteine Endopeptidases; Disseminated Intravascular Coagulation; Factor VIIa; Factor VIII; Fibrinogen; Fibrinolysis; Hemorrhage; Heparin; Humans; Leukemia, Promyelocytic, Acute; Multicenter Studies as Topic; Neoplasm Proteins; Oxides; Plasma; Platelet Count; Platelet Transfusion; Recombinant Proteins; Thromboplastin; Thrombosis; Treatment Failure; Tretinoin

2012

Other Studies

4 other study(ies) available for arsenic and Coagulation, Disseminated Intravascular

ArticleYear
Guest editorial: acute promyelocytic leukemia: change from "highly fatal to highly curable" leukemia.
    International journal of hematology, 2014, Volume: 100, Issue:1

    Topics: Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Disseminated Intravascular Coagulation; Forkhead Box Protein O3; Forkhead Transcription Factors; Humans; Leukemia, Promyelocytic, Acute; Oncogene Proteins, Fusion; Oxides; Tretinoin

2014
Microgranular acute promyelocytic leukemia presenting with leukopenia and an unusual immunophenotype.
    Hematology/oncology and stem cell therapy, 2017, Volume: 10, Issue:1

    Topics: Arsenic Trioxide; Arsenicals; Bone Marrow; Disseminated Intravascular Coagulation; Flow Cytometry; Humans; Immunophenotyping; Leukemia, Promyelocytic, Acute; Leukopenia; Male; Oxides; Treatment Outcome; Tretinoin; Young Adult

2017
Retrospective study of arsenic trioxide for childhood acute promyelocytic leukemia in China: a single-center experience.
    International journal of hematology, 2010, Volume: 91, Issue:5

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Bone Marrow; Child; Child, Preschool; China; Disseminated Intravascular Coagulation; Female; Humans; Incidence; Leukemia, Promyelocytic, Acute; Male; Oxides; Retrospective Studies; Treatment Outcome; Tretinoin

2010
Don't just stand there, do something: strategies for the prevention of early death in acute promyelocytic leukemia: a commentary.
    Blood cells, molecules & diseases, 2011, Feb-15, Volume: 46, Issue:2

    Topics: Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Disseminated Intravascular Coagulation; Hemorrhage; Humans; Leukemia, Promyelocytic, Acute; Oxides; Remission Induction; Secondary Prevention; Survival Rate; Time Factors; Treatment Failure; Tretinoin

2011